Dr. Ravi Salgia, MD, PhD, a renowned clinician-scientist, is Chair and Tenured Professor of Medical Oncology & Therapeutics
Research at City of Hope National Medical Center, in Duarte, California. Dr. Salgia also holds the Arthur and Rosalie Kaplan
Chair in Medical Oncology and is the Associate Director for Clinical Sciences Research in the City of Hope's Comprehensive
Cancer Center. Previously, Dr. Salgia was Tenured Professor of Medicine, Pathology and Dermatology, and the Director of the
Thoracic Oncology Program, and Aerodigestive Tract Program Translational Research at the University of Chicago. His research
interests focus on novel therapeutics against lung cancer. Dr. Salgia has been honored with numerous awards, including being
named one of the Top Doctors in America. He is a member of the editorial board for several top Journals and has authored or
coauthored more than 300 peer-reviewed publications, reviews, and book chapters. Prior to his tenure at University of Chicago
School of Medicine, Dr. Salgia was faculty at the Dana-Farber Cancer Institute and Harvard Medical School for a decade. Dr.
Salgia earned his undergraduate summa cum laude in mathematics, biology, and chemistry, and then his MD and PhD degrees from
Loyola University in Chicago, IL, where he also completed fellowships in neurochemistry and physiology. He continued his postgraduate
training with an internship and residency in internal medicine at The Johns Hopkins University School of Medicine in Baltimore,
MD, followed by a fellowship in medical oncology at Dana-Farber Cancer Institute in Boston, MA, during which time he also
served as a clinical fellow at Harvard Medical School in Boston.